] . The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019;16(4):e1002783. 
(864.32 KB)
(864.32 KB). Place-specific factors associated with adverse maternal and perinatal outcomes in Southern Mozambique: a retrospective cohort study. BMJ Open. 2019;9(2):e024042. (2.94 MB)
(2.94 MB). Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019;393(10169):330-339. (10.3 MB)
(10.3 MB). Protocol 13PRT/9313:The Community Level Interventions for Pre-eclampsia (CLIP) Trials: four prospective cluster randomised controlled trials comparing a package of interventions directed towards improving maternal and perinatal outcomes related to pre-ecl [Internet]. 2019 . https://clinicaltrials.gov/ct2/show/study/NCT01911494?term=01911494&rank=1
. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. Pregnancy Hypertens. 2019;15:42-50. (887.01 KB)
(887.01 KB). Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659-665. (237.99 KB)
(237.99 KB). CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial. Pregnancy Hypertens. 2018;14:15-22. (1011.52 KB)
(1011.52 KB). A comparison of maternal and newborn health services costs in Sindh Pakistan. PLoS One. 2018;13(12):e0208299. (645.08 KB)
(645.08 KB). The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settings. Reprod Health. 2018;15(1):5. (394.63 KB)
(394.63 KB). Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model. Crit Care. 2018;22(1):278. (961.71 KB)
(961.71 KB). Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique. Pregnancy Hypertens. 2018;11:26-31. (374.54 KB)
(374.54 KB). Health and socio-demographic profile of women of reproductive age in rural communities of southern Mozambique. PLoS One. 2018;13(2):e0184249. (3.25 MB)
(3.25 MB). Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study). Hypertension. 2018;71(6):1170-1177. (303.94 KB)
(303.94 KB). MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada. Implement Sci. 2018;13(1):8. (1.89 MB)
(1.89 MB). Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens. 2018;11:115-123. (501.41 KB)
(501.41 KB). Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study. Diagnostic and Prognostic Research. 2017;1(1). (428.07 KB)
(428.07 KB). Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique. Hypertension. 2017;69(3):469-474. (378.99 KB)
(378.99 KB). External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries. Hypertension. 2017;69(4):705-711. (149.83 KB)
(149.83 KB). Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia. AJP Rep. 2017;7(1):e49-e58. (184.83 KB)
(184.83 KB). Maternal and Newborn Health in Karnataka State, India: The Community Level Interventions for Pre-Eclampsia (CLIP) Trial's Baseline Study Results. PLoS One. 2017;12(1):e0166623. (2.12 MB)
(2.12 MB). Multiple Organ Dysfunction Score Is Superior to the Obstetric-Specific Sepsis in Obstetrics Score in Predicting Mortality in Septic Obstetric Patients. Crit Care Med. 2017;45(1):e49-e57. (910.16 KB)
(910.16 KB). Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review. Hypertension. 2017;70(6):1228-1237. (986.49 KB)
(986.49 KB). Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models. BMC Med. 2017;15(1):68. (932.74 KB)
(932.74 KB). A process evaluation plan for assessing a complex community-based maternal health intervention in Ogun State, Nigeria. BMC Health Serv Res. 2017;17(1):238. (925.17 KB)
(925.17 KB). Seasonal variation in geographical access to maternal health services in regions of southern Mozambique. Int J Health Geogr. 2017;16(1):1. (9.27 MB)
(9.27 MB). SOCIETAL PERSPECTIVE ON COST DRIVERS FOR HEALTH TECHNOLOGY ASSESSMENT IN SINDH, PAKISTAN. Int J Technol Assess Health Care. 2017;33(2):192-198. (266.82 KB)
(266.82 KB). Validating the Performance of the Modified Early Obstetric Warning System Multivariable Model to Predict Maternal Intensive Care Unit Admission. J Obstet Gynaecol Can. 2017;39(9):728-733.e3. (176.34 KB)
(176.34 KB). Visual or automated dipstick testing for proteinuria in pregnancy?. Pregnancy Hypertens. 2017;7:50-53. (234.13 KB)
(234.13 KB). Barriers and facilitators to health care seeking behaviours in pregnancy in rural communities of southern Mozambique. Reprod Health. 2016;13 Suppl 1:31. (1.03 MB)
(1.03 MB). Benchmarking the Hypertensive Disorders of Pregnancy. Pregnancy Hypertens. 2016;6(4):279-284. (294.88 KB)
(294.88 KB). Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial. Acta Obstet Gynecol Scand. 2016;95(7):763-76. (803.67 KB)
(803.67 KB). The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?. Hypertension. 2016;68(5):1153-1159. (476.19 KB)
(476.19 KB). Community health worker knowledge and management of pre-eclampsia in southern Mozambique. Reprod Health. 2016;13(Suppl 2):105. (882.13 KB)
(882.13 KB). Community health worker knowledge and management of pre-eclampsia in rural Karnataka State, India. Reprod Health. 2016;13(Suppl 2):113. (629.01 KB)
(629.01 KB). Community health workers' knowledge and practice in relation to pre-eclampsia in Ogun State, Nigeria: an essential bridge to maternal survival. Reprod Health. 2016;13(Suppl 2):108. (287.53 KB)
(287.53 KB). Community perceptions of pre-eclampsia and eclampsia in Ogun State, Nigeria: a qualitative study. Reprod Health. 2016;13 Suppl 1:57. (838.19 KB)
(838.19 KB). Community perceptions of pre-eclampsia and eclampsia in southern Mozambique. Reprod Health. 2016;13 Suppl 1:33. (1.01 MB)
(1.01 MB). Community perceptions of pre-eclampsia in rural Karnataka State, India: a qualitative study. Reprod Health. 2016;13 Suppl 1:35. (810.48 KB)
(810.48 KB). Community perspectives on the determinants of maternal health in rural southern Mozambique: a qualitative study. Reprod Health. 2016;13(Suppl 2):112. (1019.85 KB)
(1019.85 KB). Community's perceptions of pre-eclampsia and eclampsia in Sindh Pakistan: a qualitative study. Reprod Health. 2016;13 Suppl 1:36. (398.75 KB)
(398.75 KB). Constructing maternal morbidity - towards a standard tool to measure and monitor maternal health beyond mortality. BMC Pregnancy Childbirth. 2016;16:45. (6.99 MB)
(6.99 MB). Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?. BJOG. 2016;123(7):1135-41. (144.71 KB)
(144.71 KB). The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial). Hypertension. 2016;68(4):1049-55. (470.91 KB)
(470.91 KB). Determinants of health care seeking behaviour during pregnancy in Ogun State, Nigeria. Reprod Health. 2016;13 Suppl 1:32. (756.61 KB)
(756.61 KB). Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG. 2016;123(7):1143-51. (153.93 KB)
(153.93 KB). Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms. Pregnancy Hypertens. 2016;6(1):53-9. (821.08 KB)
(821.08 KB). The feasibility of community level interventions for pre-eclampsia in South Asia and Sub-Saharan Africa: a mixed-methods design. Reprod Health. 2016;13 Suppl 1:56. (3.54 MB)
(3.54 MB). Fetal, Infant and Maternal Outcomes among Women with Prolapsed Membranes Admitted before 29 Weeks Gestation. PLoS One. 2016;11(12):e0168285. (862.28 KB)
(862.28 KB). Guidelines for creating framework data for GIS analysis in low- and middle-income countries. The Canadian Geographer / Le Géographe canadien. 2016;60(3):320 - 332. (5.32 MB)
(5.32 MB). Health care provider knowledge and routine management of pre-eclampsia in Pakistan. Reprod Health. 2016;13(Suppl 2):104. (242.46 KB)
(242.46 KB)